Forum Diabetologicum - Issue 3/2021

Editorial

161
Komponenty metabolického syndrómu ako rizikový faktor diabetes mellitus 2. typu

165
Immune metabolic view on metabolic syndrome components

Peter Galajda, Marián Mokáň

173
Diabetes mellitus and chronic heart failure

Tomáš Bolek, Matej Samoš, Jakub Benko, Jakub Jurica, Martin Jozef Péč, Marek Cingel, Marián Mokáň

180
Obesity as a risk factor in atrial fibrillation and heart failure

Jakub Jurica, Martin Jozef Péč, Jakub Benko, Tomáš Bolek, Matej Samoš, Peter Galajda, Marián Mokáň

187
Metabolic syndrome in kidney transplant recipients

Karol Graňák, Matej Vnučák, Monika Beliančinová, Margaréta Pytliaková, Ivana Dedinská

193
Metabolic syndrome and intestinal microbiome

Simona Horná, Juraj Krivuš, Renáta Michalová, Peter Galajda, Marián Mokáň

197
Obesity and psoriasis: the context of new knowledge

Martin Jozef Péč, Monika Kučeríková, Jakub Jurica, Jakub Benko, Tomáš Bolek, Juraj Sokol, Tatiana Péčová, Matej Samoš, Peter Galajda, Marián Mokáň

201
IGlarLixi represents a better choice compared to biphasic insulin when intensifying basal insulin therapy

Emil Martinka


207
Benefit of gliflozines on atherosclerosis?

Marián Mokáň, Peter Galajda

213
Oral semaglutide: the future of GLP1 receptor agonism?

Matej Samoš, Marián Mokáň

218
DAPA-CKD Study results in the context of preceding studies with gliflozins in the relation to chronic kidney disease

Ivan Tkáč


Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account